Partnering Business Model
Amarantus BioSciences believes that it has far more viable development opportunities than any single company could adequately exploit. As such, Amarantus intends to partner product development with leading academic institutions, research institutes, hospitals, clinics, small to large scale biotechnology, pharmaceutical, diagnostic and device companies to achieve maximum value creation for its high-value, multi-purposed discoveries.
Amarantus BioSciences is interested in partnering opportunities for its product candidates that will allow development of adjunct -products that will address diseases caused by poorly served biological pathways. We intend to generate revenues through collecting up-front and milestone payments as our candidates advance through pre-clinical and clinical development, and royalties upon commercialization.
